Illustrative image – not actual.
Spain is looking to invest in bulk drug parks in India which will support the active pharmaceutical ingredients (API) supply chain for both sides. The discussion regarding the investment is at a preliminary stage, and further rounds of consultation will take the initiative forward.
The Department of Pharmaceuticals, Government of India (GoI) had participated in the 12th session of the India-Spain Joint Commission for Economic Cooperation (JCEC) meeting held in April, 2023 in New Delhi. Both Spain and India intend to engage through mutual collaboration, and have agreed to further cooperation in pharmaceuticals, technology, innovation, and other sectors.
The complexity of the supply chain from upstream to downstream is being explored for streamlining based on planning, investment, visibility and other goals.
In the area of API and intermediates production, India’s major supplies come from other countries, including China.
